» Authors » Daniela Verzola

Daniela Verzola

Explore the profile of Daniela Verzola including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 90
Citations 1315
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Picciotto D, Balbi M, Rosa G, Esposito P, Russo E, Sofia A, et al.
Nutr Metab Cardiovasc Dis . 2025 Jan; 103812. PMID: 39809639
Background And Aims: The adipocyte-derived adiponectin (APN) has potent insulin-sensitizing and anti-inflammatory properties. The adipose tissue is known to be the main source for APN in the circulation, but sites...
2.
Ravera S, Puddu A, Bertola N, Verzola D, Russo E, Maggi D, et al.
Int J Mol Sci . 2025 Jan; 25(24. PMID: 39769402
The retinal pigment epithelium (RPE) contributes to retinal homeostasis, and its metabolic dysfunction is implied in the development of retinal degenerative disease. The isoform M2 of pyruvate kinase (PKM2) is...
3.
Verzola D, Rumeo N, Alberti S, Loiacono F, La Maestra S, Passalacqua M, et al.
Heliyon . 2024 Nov; 10(20):e39426. PMID: 39498083
Microplastics (MPs) accumulate in tissues, including kidney tissue, while Bisphenol A (BPA) is a plasticizer of particular concern. At present, the combined effects of MPs and BPA are unexplored in...
4.
Angeletti A, Esposito P, Verzola D, Cravedi P, La Porta E
Kidney Int . 2024 Sep; 106(4):757. PMID: 39304274
No abstract available.
5.
Picciotto D, Maccio L, Verzola D, Baciga F, Momente C, Russo E, et al.
Kidney Blood Press Res . 2024 May; 49(1):457-471. PMID: 38815556
Background: Chronic kidney disease (CKD) is a progressive systemic condition characterized by numerous complications. Among these, alterations in skeletal muscle physiology, such as sarcopenia, are particularly significant, as they are...
6.
Russo E, Zanetti V, Maccio L, Benizzelli G, Carbone F, La Porta E, et al.
Clin Kidney J . 2024 May; 17(5):sfae133. PMID: 38803397
Anti-aging therapy is the latest frontier in the world of medical science, especially for widespread diseases such as chronic kidney disease (CKD). Both renal aging and CKD are characterized by...
7.
Moriero M, Verzola D, Bertolotto M, Minetti S, Contini P, Ramoni D, et al.
Nutr Metab Cardiovasc Dis . 2024 Apr; 34(8):1874-1878. PMID: 38664124
Background And Aims: While serum osteopontin (OPN)'s established role in cardiometabolic risk is recognized, its potential as a predictor of metabolic syndrome (MetS) improvement through a urine assay has not...
8.
Gaggero G, Bertolotto M, Verzola D, Ferro J, Fiaschi P
J Rheum Dis . 2024 Apr; 31(2):130-132. PMID: 38559793
No abstract available.
9.
Barisione C, Verzola D, Garibaldi S, Altieri P, Furfaro A, Nitti M, et al.
J Cell Mol Med . 2024 Mar; 28(7):e18192. PMID: 38506079
In the last decade, extensive attention has been paid to the uremic toxin indoxyl sulphate (IS) as an inducer of cardiac fibroblast (cFib) activation and cardiac fibrosis in chronic kidney...
10.
Verzola D, Saio M, Milanesi S, Picciotto D, Frascio M, Brunori G, et al.
Nephrol Dial Transplant . 2024 Feb; 39(7):1201-1203. PMID: 38400552
No abstract available.